MoneyWorks4Me

Syncom Formulations (India) informs about company updates

10 Jul 2017 Evaluate

Syncom Formulations (India) has informed about Filing of statement relating to Investor Complaints u/r 13(3) of SEBI (LODR) Regulations, 2015 for the Quarter ended 30th June, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..